Biotechnology Stocks
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 5006 |  SLXN Silexion Therapeutics Corp - Ordinary Shares | 0.23 USD | -8.00% | -20.69% | -43.90% | -85.71% | 1.28 M USD | ||
| 5011 |  VRAX Virax Biolabs Group Limited - Ordinary Shares | 1.99 USD | -5.69% | -11.16% | -27.11% | +192.65% | 1.15 M USD | ||
| 5046 |  SCNI Scinai Immunotherapeutics Ltd - American Depositary Shares | 1.21 USD | +7.08% | -6.92% | -27.98% | +59.21% | 419.65 K USD | ||
| 5092 |  BDRX Biodexa Pharmaceuticals plc - American Depositary Shares | 0.52 USD | -7.14% | -16.13% | -35.00% | -62.86% | 46.97 K USD | ||
| 5095 |  CDT CDT Equity Inc. - Common Stock | 0.80 USD | -4.76% | -37.50% | +95.12% | +48.15% | 25.17 K USD | ||
| 5100 |  CMND Clearmind Medicine Inc. - Common Shares | 6.60 USD | 0.00% | +816.67% | +560.00% | +573.47% | 13.04 K USD | ||
| 5134 |  GMAB Genmab A/S - American Depositary Shares | 36.05 USD | -1.64% | +4.83% | +11.06% | +13.01% | 0 USD | ||
| 5166 |  OCS Oculis Holding AG - Ordinary shares | 8.66 USD | +1.88% | -1.81% | -23.70% | -59.72% | 0 USD | ||
| 5179 |  ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 USD | +10.39% | -1.59% | +3.61% | +817.75% | 0 USD | ||
| 5250 |  NVO Novo Nordisk A/S | 38.16 USD | -0.26% | +1.38% | -14.44% | -34.90% | 0 USD | ||
| 5466 |  CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1149 USD | -11.62% | -11.62% | 0.00% | +198.44% | 0 USD | ||
| 6285 |  ADAP Adaptimmune Therapeutics plc - American Depositary Shares | 0.05 USD | 0.00% | 0.00% | -61.54% | -76.19% | 0 USD | ||
| 6408 |  RVMDW Revolution Medicines, Inc. - Warrant | 9.4400 USD | -12.27% | -19.45% | -17.19% | +3142.87% | 40.32 B USD | ||
| 6637 |  NAMSW NewAmsterdam Pharma Company N.V. - Warrant | 12.6500 USD | 0.00% | 0.00% | +1.04% | -39.33% | 2.54 B USD | ||
| 6709 |  DRTSW Alpha Tau Medical Ltd. - Warrant | 3.5600 USD | -1.11% | -12.10% | -11.66% | +917.14% | 1.23 B USD | ||
| 6823 |  YDESW YD Bio Limited - Warrants | 0.5000 USD | -23.08% | -28.57% | +33.33% | -76.30% | 409.87 M USD | ||
| 6953 |  SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 USD | -27.87% | -40.94% | -42.48% | -68.79% | 262.95 M USD | ||
| 7057 |  ENGNW enGene Therapeutics Inc. - Warrants | 0.1700 USD | 0.00% | -32.00% | -5.66% | -79.01% | 119.29 M USD | ||
| 7102 |  FBIOP Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock | 17.78 USD | -1.33% | +9.75% | -4.10% | +149.72% | 76.87 M USD | ||
| 7105 |  NTRBW Nutriband Inc. - Warrant | 0.5500 USD | 0.00% | -32.10% | +83.33% | -67.65% | 75.37 M USD |
Nouvelles Biotechnology Stocks
Le médicament de Pharvaris contre l’angiœdème héréditaire soulage plus vite
Raymond James initie une couverture de Kymera Therapeutics avec une note de surperformance
Raymond James initie la couverture de Nektar avec une note Performance Marché
L’action Palisade Bio initiée à Surperformance par Raymond James
Raymond James réitère sa note sur l’action Liquidia malgré les dépôts juridiques
Tenax Therapeutics suspend temporairement le recrutement dans l’essai LEVEL-2 de TNX-103 afin de modifier les critères ; demande une réunion avec la FDA
Ginkgo Bioworks soutient le programme NSF X-Labs avec son laboratoire
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |